Get Invoved
Help Shape The Future Of Managed Access
Join the Global Managed Access Benchmark
The Global Managed Access Benchmark (GMAB) is a new industry initiative bringing pharmaceutical companies and Managed Access leaders together to build a clearer picture of how Managed Access is structured, governed and delivered globally.
We’re now inviting pharmaceutical companies and industry leaders to get involved.
Get Involved
Participate In The Benchmark
We are inviting pharmaceutical companies involved in Managed Access, (also known as Expanded Access, Early Access and Compassionate Use) to contribute to the inaugural research and discover how their Managed Access capability compares with wider industry practice.
Strategy & Governance How Managed Access is positioned, owned and governed within the organization
Better governance
Greater operational control
Improved compliance
More evidence
Reduced fragmentation
Scalable global operations
Stronger strategic decision-making
Strategy & Governance How Managed Access is positioned, owned and governed within the organization
Strategy & Governance How Managed Access is positioned, owned and governed within the organization
Strategy & Governance How Managed Access is positioned, owned and governed within the organization
Strategy & Governance How Managed Access is positioned, owned and governed within the organization
Strategy & Governance How Managed Access is positioned, owned and governed within the organization
Built by Managed Access experts
The difference isn't simply the technology.
It's the experience behind it.
Maprium was built by professionals who have spent decades working within Managed Access—designing programs, solving operational challenges and understanding the realities pharmaceutical companies face every day.
That expertise is embedded throughout the platform.
Take a personalized 15-minute tour
To request a demo, discuss your access challenges or learn more about Maprium, please use the secure form.